Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Current Deferred Revenue (2016 - 2025)

Healthstream (HSTM) has disclosed Current Deferred Revenue for 16 consecutive years, with $88.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 4.97% to $88.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $88.4 million, a 4.97% increase, with the full-year FY2025 number at $88.4 million, up 4.97% from a year prior.
  • Current Deferred Revenue was $88.4 million for Q4 2025 at Healthstream, up from $85.7 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $102.0 million in Q1 2025 to a low of $73.8 million in Q4 2021.
  • A 5-year average of $85.2 million and a median of $83.9 million in 2023 define the central range for Current Deferred Revenue.
  • Biggest YoY gain for Current Deferred Revenue was 22.14% in 2021; the steepest drop was 9.07% in 2021.
  • Healthstream's Current Deferred Revenue stood at $73.8 million in 2021, then increased by 7.66% to $79.5 million in 2022, then increased by 5.23% to $83.6 million in 2023, then rose by 0.72% to $84.2 million in 2024, then rose by 4.97% to $88.4 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Current Deferred Revenue are $88.4 million (Q4 2025), $85.7 million (Q3 2025), and $88.4 million (Q2 2025).